Nutra Pharma Corp. (NPC)

Contact

Nutra Pharma is developing an innovative pipeline of biopharmaceutical products

Signup to receive news and announcements from Nutra Pharma

Name:

Email:

Yes, in addition to e-alerts, please sign me up to receive Nutra Pharma Blog postings via email.

Contact

Nutra Pharma Headquarters We welcome all correspondence from those interested in our company, products, and research. If you require immediate assistance, please call our investor relations office toll-free at (877) 895-5647 or our corporate office at (954) 509-0911.

Mailing Address

Nutra Pharma Corporation
791 Park of Commerce Blvd., Suite 300
Boca Raton, FL 33487 USA

Investor Relations: (877) 895-5647
Office: (954) 509-0911
Fax: (877) 895-5647

November 17, 2008
Nutra Pharma Announces Provision of RPI-78M under Compassionate Release to Adrenomyeloneuropathy (AMN) Patients

August 14, 2008
Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN)

August 6, 2008
Nutra Pharma Announces Collaborative Agreement with Centers for Disease Control and Prevention (CDC)

Click Here for an Update on the Phase IIb Clinical Trial Data.